As per latest reports, it has been warned by the US Food and Drug Administration (FDA) that a French manufacturer of breast implants are now terror stricken due to possibilities related to rupturing of highly imperative quality control infringements in context to saline implants that transpired way back in 2000.

Earlier in May 2000, the concerned authorities carried out an evaluation of a French factory that was being managed by Poly Implant Prothese (PIP). As part of the inspection, the FDA then delivered a strict warning letter on June 22, 2000, wherein it provided mandatory words of caution related to saline implants being carried out at the facility and clearly stated that all such implants are nothing but adulterated.

In this regard, a letter has been issued to the AFP for the sake of outlining a variety of quality assurance issues and deep-rooted concerned regarding the same. In the letter, the FDA has clearly delivered an admonition that it may be symptomatic of solemn highlighting issues in various systems related to manufacturing, quality assurance, and more.

At present, the firm is facing investigations not in context to saline implants, but the probes are mainly focused on scrutinizing silicone implants. PIP is being suspected for fraudulently employing a gel of extremely poor-quality for devices meant for dealing with any sort of leakage as well as inflammation issues.

In the meantime, the health ministry of France has suggested around 30,000 women, those who’ve already undergone PIP silicone breast implants in France, to get rid of the potentially dangerous breast implants as soon as possible.

While expressing her opinion in this regard, FDA Spokesperson Erica Jefferson claimed: “Our warning letter was publicly available in 2000. Given the timeframe, I haven't been able to confirm whether any information was shared with France”. Though breast implants have no proven adverse cancer effects as of now, the prostheses can perhaps result in rupture.